USA Insider Trading Pulse — September 08, 2026

CEO-adjacent insider Andrew Macdonald bought 70,000 shares for $5.31M at ~$75.65, the largest open-market insider purchase in the dataset. This signals strong conviction in Uber's valuation and growth trajectory, especially given the size relative to his existing holdings

CEO Todd Schwartz bought 3,500 shares at $7.35, deploying $25.7K of personal capital. This insider buying at a low absolute price suggests management sees significant upside in this fintech name, potentially ahead of an earnings inflection

CEO Matthew McLaughlin bought 20,000 shares at ~$5.10 for $101.7K, a material purchase for a small-cap CEO. This signals confidence in the company's strategic turnaround and suggests the stock may be undervalued relative to intrinsic value

Director Ralf Speth bought 68,000 shares at ~$3.15 for $215K, adding to his existing 269K share position. This aggressive insider buying at a low price point signals a potential value opportunity in this industrial technology company

COO Tamari Shahar sold 24,999 shares at $38.41 for $960K, and President Nir Debbi sold 228 shares at $39.21. While the President's sale is small, the COO's $960K sale under a 10b5-1 plan suggests a planned diversification, but the timing near recent highs warrants monitoring

Four insiders (CSO, CMO, CFO, NA CEO) sold small amounts totaling ~$17K at ~$52.30. While individually immaterial, the coordinated selling across multiple C-suite executives on the same day creates a negative signal about management's near-term outlook

10% owner Saba Capital sold 271,939 shares at ~$15.28 for $4.15M, a significant reduction. This is a strong negative signal from a sophisticated activist investor, potentially indicating a loss of conviction in the trust's strategy or valuation

Director Birger Meyer-Gloeckner sold 1,531 shares at $28.50 for $43.6K while exercising 13,459 options. The net effect is a partial monetization of options, but the sale at a relatively low price for a cyclical shipping stock could signal a peak-cycle view

10% owner Saba Capital bought 11,800 shares at ~$12.30 for $145K, increasing its stake to 1.63M shares. This accumulation, alongside similar buys in Gabelli Healthcare, signals a bullish view on closed-end fund discounts and potential activist catalysts

CEO Jiang Pengfei was awarded 140,000 Class B shares at $0.00, a zero-cost grant that aligns management with shareholders. While not a cash purchase, the magnitude of the award (140K shares) is a strong retention and incentive signal

CBO David Wambeke bought 33,333 shares at $2.01 for $67K, a significant open-market purchase for a micro-cap medical device company. This signals insider confidence in the company's commercial progress or upcoming catalysts

Director Perry Hines sold 3,237 shares at $52.22 for $169K, and General Counsel Donald Carley sold 2,054 shares at $52.28 for $107K. Two insiders selling on the same day at similar prices suggests a coordinated view that the stock is fairly valued or facing headwinds

Four senior executives (CSO, CMO, CFO, NA CEO) sold shares on the same day at ~$52.30. While the dollar amounts are small ($1.7K-$6.4K), the pattern of simultaneous selling by the entire executive team is a red flag for sentiment, potentially indicating a lack of confidence in near-term performance

COO Tamari Shahar sold $960K worth of shares at $38.41, the largest insider sale in the dataset by dollar value. While executed under a 10b5-1 plan, the size of the sale relative to the insider's holdings (3.83M shares post-sale) suggests a significant portfolio rebalancing that could precede negative news

Saba Capital's $4.15M sale of 271,939 shares represents a material reduction by a sophisticated activist investor. This could signal that Saba has lost confidence in the trust's ability to generate returns or that it is rotating capital into higher-conviction positions

Director Perry Hines and General Counsel Donald Carley sold a combined $276K worth of stock on the same day at ~$52.25. The simultaneous selling by both a board member and a senior officer suggests a shared bearish view on the stock's near-term prospects

Director Birger Meyer-Gloeckner sold 1,531 shares at $28.50 while exercising options. Given ZIM's cyclical nature and volatile earnings, insider selling at this price point could indicate that management views the current shipping cycle as peaking

President-APAC Elie Melhem sold 1,096 shares at $359.55 for $394K, a significant sale for a regional executive. This could signal headwinds in the APAC region or a personal diversification need, but the size warrants attention

CEO Sean Desmond exercised 8,064 options at $4.98 and immediately sold the shares at $23.66 for $191K. While this is a standard cashless exercise, the decision to sell rather than hold the shares suggests a lack of conviction in the stock at current levels

10% owner Penny Sanford disposed of 26.7 million shares. While the filing does not specify the nature of the disposition, such a large disposal by a major shareholder is a significant red flag and could indicate a loss of confidence or a strategic exit

CFO Jennifer Kong-Picarello was awarded only 21 shares at $61.15, a trivial award of $1.28K. While this is a routine compensation event, the tiny size of the award relative to the executive's role could signal a lack of retention incentives or a struggling compensation structure

SVP and CAO Theodore Huizenga sold 161 shares at $13.99 for $2.25K. While small, the sale by the chief accounting officer, who has intimate knowledge of financial controls, is a minor negative signal

Andrew Macdonald's $5.31M purchase at $75.65 is a massive vote of confidence. With Uber's strong market position and the insider buying at a significant dollar amount, this signals a potential buying opportunity ahead of the next earnings report

CEO Matthew McLaughlin bought $101.7K worth of stock at ~$5.10, a material investment for a small-cap CEO. This suggests the company's turnaround efforts are gaining traction, and the stock may be undervalued. Trading at a low absolute price, this could be a high-risk, high-reward opportunity

Director Ralf Speth bought $215K worth of shares at ~$3.15, adding to his already large position. This insider buying at a low price point suggests the stock is deeply undervalued, potentially ahead of a catalyst like a new contract or earnings improvement

CEO Todd Schwartz bought 3,500 shares at $7.35 for $25.7K. In a fintech company trading at a low absolute price, this insider purchase signals management's belief that the stock is undervalued relative to its earnings power or growth prospects

CBO David Wambeke bought 33,333 shares at $2.01 for $67K, a significant purchase for a micro-cap. This signals insider confidence in the company's commercial progress, potentially ahead of a product approval or partnership announcement

Saba Capital's purchase of 11,800 shares at ~$12.30 adds to its 1.63M share position. Saba is known for activist campaigns in closed-end funds, often pushing for liquidity events or tender offers. This accumulation could signal a catalyst for narrowing the fund's discount

Saba Capital bought 500 shares at $10.08, adding to its 2.16M share position. Similar to the Ellsworth fund, Saba's presence suggests potential activist pressure to unlock value, making this a play on the fund's discount narrowing

CEO Jiang Pengfei was awarded 140,000 Class B shares at zero cost. While not a purchase, the magnitude of the award (140K shares) strongly aligns management with shareholders. This could precede a growth phase or a strategic initiative

Two directors (Katherine Shattuck and Frank Pellegrino) bought shares at $26.17 under a 10b5-1 plan. While the dollar amounts are small ($209 and $4.66K), the use of a pre-arranged plan signals a long-term bullish view on this regional bank, which could benefit from a stable rate environment

10% owner Horizon Kinetics bought 1 share at $360.03. While the trade size is trivial, the fact that a sophisticated asset manager is adding to its 3.39M share position signals a long-term bullish view on this unique land and royalty company

Three Israeli tech companies (Global-E Online, Nayax, and Kamada) saw insider selling on the same day. Global-E's COO sold $960K, Nayax's entire C-suite sold small amounts, and Kamada's VP sold options. This pattern suggests a regional or sector-specific bearish sentiment among insiders in Israeli growth tech

Saba Capital Management is actively rotating its portfolio, selling $4.15M of BlackRock ESG Capital Allocation Term Trust while buying into Ellsworth Growth & Income Fund and Gabelli Healthcare & WellnessRx Trust. This suggests a targeted strategy favoring closed-end funds with wider discounts or specific activist catalysts

The largest insider purchases by dollar value are concentrated in value or turnaround situations: Uber ($5.31M), SCHMID Group ($215K), Comscore ($101.7K), and NeuroOne ($67K). This pattern indicates that insiders see the most opportunity in beaten-down or undervalued names rather than high-growth tech

CEOs at OppFi ($25.7K), Comscore ($101.7K), and NeuroOne ($67K) made open-market purchases, signaling strong conviction in their respective turnarounds. This contrasts with the selling seen at larger growth companies and suggests a flight to value within insider sentiment

28 of 50 filings (56%) were non-cash compensation events (RSUs, stock options, dividend equivalents). While these are neutral signals, the prevalence of awards over cash purchases suggests that insiders are not actively deploying personal capital, which is a mildly bearish aggregate signal

Citizens & Northern Corp saw director buying under a 10b5-1 plan, while Horace Mann Educators saw dual insider selling. This mixed signal in the financial sector suggests a lack of clear consensus among insiders, with regional banks seeing buying and insurance companies seeing selling

Andrew Macdonald's $5.31M insider purchase is a strong bullish signal. Watch for the next earnings call (expected late October 2026) for confirmation of the growth trajectory that insiders are betting on

COO Tamari Shahar's $960K sale under a 10b5-1 plan warrants monitoring. Watch for the next quarterly filing to see if selling continues or if the company provides guidance that justifies the insider's diversification

Saba Capital's $4.15M sale is a significant negative signal. Watch for further filings from Saba to see if this is the start of a full exit, and monitor the trust's discount to NAV for potential widening

CEO Matthew McLaughlin's $101.7K purchase is a strong turnaround signal. Watch for the next earnings report (likely November 2026) for evidence of the operational improvements that the CEO is betting on

The coordinated C-suite selling on September 8 is a red flag. Watch for any press releases or earnings pre-announcements that could explain the insider pessimism, and monitor for further insider selling

10% owner Penny Sanford's disposal of 26.7 million shares is a major event. Watch for a Schedule 13D filing or press release explaining the disposition, and monitor the stock for increased volatility

Director Ralf Speth's $215K purchase at ~$3.15 is a strong value signal. Watch for any corporate announcements (new contracts, earnings improvements) that could catalyze the stock, and monitor for additional insider buying

CEO Todd Schwartz's $25.7K purchase at $7.35 is a bullish signal for this fintech. Watch for the next earnings call for updates on loan performance and profitability, which would validate the insider's conviction